GEN.ORPH
Gen.Orph focuses its efforts on providing patients and the international medical community with efficient and affordable orphan drugs for the treatment of certain rare diseases, drugs that have been abandoned by the industry but retain attractive medical and economic potential, as well as innovative and / or classic drugs for frequent diseases
GEN.ORPH
Industry:
Health Care Medical
Address:
Saint-cloud, Ile-de-France, France
Country:
France
Website Url:
http://www.gen-orph.com
Status:
Active
Contact:
+0664108202
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Amazon AJAX Libraries API OpenResty
Official Site Inspections
http://www.gen-orph.com
- Host name: ec2-54-183-102-22.us-west-1.compute.amazonaws.com
- IP address: 54.183.102.22
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Gen.Orph"
Genorph - La solution aux maladies orphelines
Gen.Orph concentre ses efforts sur la mise à disposition des patients et du corps médical international de médicaments orphelins utiles et abordables en vue du traitement de certaines maladies rares, de médicaments classiques, โฆSee details»
Gen.Orph - Crunchbase Company Profile & Funding
Gen.Orph focuses its efforts on providing patients and the international medical community with efficient and affordable orphan drugs for the treatment of โฆSee details»
Gen.Orph Company Profile 2024: Valuation, Funding & Investors
Gen.Orph General Information Description. Developer of generic orphan drugs designed to treat rare diseases in children. The company's drugs offer patients and medical teams worldwide โฆSee details»
Orphanet: GEN.ORPH
GEN.ORPH. institutions.detail.person.activities. Marketing authorisation holder Gen.Orph Gen.Orph 100 Rue Louis Blanc, TSA / Batiment Copenhague 60160 MONTATAIRE FRANCE โฆSee details»
GEN ORPH - Crédit Mutuel Innovation
Gen Orph optimises access for healthcare professionals and patients to effective and affordable medicines to treat certain rare diseases. Discover the website of the company. 3 employees; Marketing of 5 medicines against rare diseases ...See details»
Gen.Orph - Overview, News & Similar companies | ZoomInfo.com
View Gen.Orph (www.gen-orph.com) location in France , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
GEN.ORPH - Dun & Bradstreet
Gen.orph. d&b business directory home / business directory / wholesale trade / merchant wholesalers, nondurable goods / drugs and druggists' sundries merchant wholesalers / france โฆSee details»
Gen.Orph - Crunchbase
Gen.Orph focuses its efforts on providing patients and the international medical community.See details»
GEN.ORPH Company Profile | , Norway - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GEN.ORPH of . Get the latest business insights from Dun & Bradstreet.See details»
Gen.Orph - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Gen.Orph focuses its efforts on providing patients and the international medical community.See details»
Abacus Medicine Pharma Services and Gen.Orph Sign Partnership โฆ
Abacus Medicine Pharma Services (AMPS) and Gen.Orph are proud to announce the signing of a partnership agreement for the exclusive marketing and distribution of Miglustat Gen.Orph in โฆSee details»
GEN ORPH - creditmutuel-equity.eu
Gen Orph optimises access for healthcare professionals and patients to effective and affordable medicines to treat certain rare diseases. Discover the website of the company. 3 employees; โฆSee details»
EU Risk Management Plan for Ibuprofen Gen.Orph 5 mg/mL โฆ
This is a summary of the risk management plan (RMP) for Ibuprofen Gen.Orph 5 mg/mL solution for injection. The RMP details important risks of buprofIen Gen.Orph 5 mg/mL solution for โฆSee details»
Ibuprofen Gen.Orph | European Medicines Agency (EMA)
Ibuprofen Gen.Orph is a medicine used to treat โpatent ductus arteriosusโ in newborn premature babies who were born six or more weeks too early (less than 34 weeks gestational age). โฆSee details»
Gen.Orph Company Profile | Unknown, Unknown, Belgium
Find company research, competitor information, contact details & financial data for Gen.Orph of Unknown, Unknown. Get the latest business insights from Dun & Bradstreet.See details»
Ibuprofen Gen.Orph, INN-Ibuprofen - ema.europa.eu
Treatment with Ibuprofen Gen.Orph should only be carried out in a neonatal intensive care unit under the supervision of an experienced neonatologist. Posology A course of therapy is โฆSee details»
Gen.orph Company Profile | , Norway | Competitors, Financials ...
Find company research, competitor information, contact details & financial data for Gen.orph of . Get the latest business insights from Dun & Bradstreet.See details»
Open Orphan - Crunchbase Company Profile & Funding
Stock Symbol LSE:ORPH ; Company Type For Profit; Contact Email [email protected]; Phone Number +353 (01) 6440007; Open Orphan Open Orphan is a rapidly growing niche โฆSee details»
Ibuprofen Gen.Orph - news.pda.org
Overview Ibuprofen Gen.Orph is a medicine used to treat โpatent ductus arteriosusโ in newborn premature babies who were born six or more weeks too ...See details»
Miglustat Gen.Orph 100 mg hard capsules - medicines
Miglustat Gen.Orph may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable (see sections 4.4 and 5.1). Miglustat Gen.Orph is indicated for the โฆSee details»